Recent News View All News

CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer

Apr 27, 2026 8:30am EDT

CytoDyn to Host Investor Webcast

Apr 23, 2026 8:30am EDT

View All News

Upcoming Events View IR Calendar

Investor Webcast

Apr 30, 2026 • 1:00 am PDT

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Sign Up